Videos
Articles
Citations: 3335
Allergic rhinitis and its impact on asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen)
Bousquet, J., Khaltaev, N., Cruz, A.A., Denburg, J., Fokkens, W.J., Togias, A. et al. Allergy. 2008; 63: 8-160
Citations: 2330
The global burden of asthma: executive summary of the GINA Dissemination Committee Report
Masoli, M., Fabian, D., Holt, S., Beasley, R. Allergy. 2004; 59: 469-478
Citations: 1328
Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China
Zhang, J.-J., Dong, X., Cao, Y.-Y., Yuan, Y.-D., Yan, Y.-Q., Akdis, C., A. and Gao, Y.-D. Allergy. 2020; 75: 1730– 1741
Citations: 1300
A revised nomenclature for allergy - An EAACI position statement from the EAACI nomenclature task force
Johansson, S.G.O., Hourihane, J., Bousquet, J., Bruijnzeel-Koomen, C., Dreborg, S., Haahtela, T. et al. Allergy. 2001; 56: 813-824
Citations: 885
Position Paper - Allergen Standardization and Skin-Tests
Dreborg, S. and Frew, A. Allergy. 1993; 48: 49-54
Citations: 794
Allergenic pollen and pollen allergy in Europe
D’Amato, G., Cecchi, L., Bonini, S., Nunes, C., Annesi-Maesano, I., Behrendt, H. et al. Allergy. 2007; 62: 976-990
Citations: 760
Benefits of omalizumab as add-on therapy in patients with severe persistent asthma who are inadequately controlled despite best available therapy (GINA 2002 step 4 treatment): INNOVATE
Humbert, M., Beasley, R., Ayres, J., Slavin, R., Hébert, J., Bousquet, J. et al. Allergy. 2005; 60: 309-316
Citations: 757
The EAACI/GA(2)LEN/EDF/WAO Guideline for the definition, classification, diagnosis, and management of urticaria: the 2013 revision and update
Zuberbier, T., Aberer, W., Asero, R., Bindslev-Jensen, C., Brzoza, Z., Canonica, G., W., et al. Allergy. 2014; 69: 868– 887
Citations: 664
Specific immunotherapy has long-term preventive effect of seasonal and perennial asthma: 10-year follow-up on the PAT study
Jacobsen, L., Niggemann, B., Dreborg, S., Ferdousi, H.A., Halken, .S., Høst, A. et al. Allergy. 2007; 62: 943-948
Citations: 617
EAACI Food Allergy and Anaphylaxis Guidelines: diagnosis and management of food allergy
Muraro, A, Werfel, T, Hoffmann-Sommergruber, K, Roberts, G, Beyer, K, Bindslev-Jensen, C, et al. Allergy 2014; 69: 1008– 1025
Citations: 1328
Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China
Zhang, J.-J., Dong, X., Cao, Y.-Y., Yuan, Y.-D., Yan, Y.-Q., Akdis, C., A. and Gao, Y.-D. Allergy. 2020; 75: 1730– 1741
Citations: 245
Immune response to SARS-CoV-2 and mechanisms of immunopathological changes in COVID-19
Azkur, A.,K., Akdis, M., Azkur, D., Sokolowska, M., van de Veen, W., Brüggen, M.,C. et al. Allergy. 2020; 75: 1564– 1581
Citations: 169
COVID-19 in a designated infectious diseases hospital outside Hubei Province, China
Cai, Q., Huang, D., Ou, P., Yu, H., Zhu, Z., Xia, Z. et al. Allergy. 2020; 75: 1742– 1752
Citations: 119
Eleven faces of coronavirus disease 2019
Dong, X., Cao, Y.-Y., Lu, X.-X., Zhang, Du, H., J.-J., Yan, Y.-Q. et al. Allergy. 2020; 75: 1699– 1709
Citations: 115
Distribution of ACE2, CD147, CD26, and other SARS-CoV-2 associated molecules in tissues and immune cells in health and in asthma, COPD, obesity, hypertension, and COVID-19 risk factors
Radzikowska, U., Ding, M., Tan, G., Zhakparov, D., Peng, Y., Wawrzyniak, P. et al. Allergy. 2020; 75: 2828– 2844
Citations: 77
Distinct characteristics of COVID-19 patients with initial rRT-PCR-positive and rRT-PCR-negative results for SARS-CoV-2
Zhang, J.-j., Cao, Y.-y., Dong, X., Wang, B.-c., Liao, M.-y., Lin, J. et al. Allergy. 2020; 75: 1809-1812
Citations: 56
Is BCG vaccination affecting the spread and severity of COVID-19?
Ozdemir, C., Kucuksezer, U.,C. and Tamay, Z.,U. Allergy. 2020; 75: 1824-1827
Citations: 55
Intranasal corticosteroids in allergic rhinitis in COVID-19 infected patients: An ARIA-EAACI statement
Bousquet, J., Akdis, C.,A., Jutel, M., Bachert, C., Klimek, L., Agache, I. et al. Allergy. 2020; 75: 2440-2444
Citations: 52
Is global BCG vaccination-induced trained immunity relevant to the progression of SARS-CoV-2 pandemic?
Gursel, M. and Gursel, I. Allergy. 2020; 75: 1815-1819
In search of the golden ratio for cannabis allergy: utility of specific allergen-to-total IgE ratios
Decuyper, I.I., Rihs, H.-P., Mertens, C.H., er al. Allergy. First published: 29 July 2021
Engineering a safe monoclonal anti-human IL-2 that is effective in a murine model of food allergy and asthma
Klein, M., Misme-Aucouturier, B., Cheminant, M.-A., et al. Allergy. First published: 29 July 2021
EAACI Biologicals Guidelines – Omalizumab for the treatment of chronic spontaneous urticaria in adults and in the paediatric population 12-17 years old
Agache, I., Akdis, C., Akdis, M., et al. Allergy. First published: 29 July 2021
IL-10 induces IgG4 production in NOD-scid Il2rγnullmice humanized by engraftment of peripheral blood mononuclear cells
Cevhertas, L., Ma, S., Stanic, B., et al. Allergy. First published: 29 July 2021
Local inflammation enables a basophil-neuronal circuITCH in atopic dermatitis
López-Sanz, C., Jimenéz-Saiz, R. and Ehlers, A.M. Allergy. First published: 28 July 2021
Open-label follow-on study evaluating the efficacy, safety, and quality of life with extended daily oral immunotherapy in children with peanut allergy
Fernandez-Rivas, M., Vereda, A., Vickery, B.P., et al. Allergy First published: 28 July 2021
One hundred and ten years of Allergen Immunotherapy: A journey from empiric observation to evidence
Pfaar, O., Bousquet, J., Durham, S., et al. Allergy. First published: 27 July 2021
IRE1 and PERK signaling regulates inflammatory responses in a murine model of contact hypersensitivity
Klimek, L., Agache, I., Cooke, E., Jutel, M., Akdis, C.A. and O'Hehir, R. Allergy. First published: 27 July 2021
Adverse COVID-19 Outcomes in Immune Deficiencies; Inequality Exists Between Subclasses
Karakoc Aydiner, E., Bilgic Eltan, S., Babayeva, R., et al. Allergy. First published: 27 July 2021
Low oxygen-levels decrease adaptive immune responses and ameliorate experimental asthma in mice
Hochgerner, M., Sturm, E.M., Schnoegl, D., et al. Allergy. First published: 26 July 2021
Newly defined allergens in the WHO/IUIS Allergen Nomenclature Database during 01/2019-03/2021
Sudharson, S., Kalic, T., Hafner, C. and Breiteneder, H. Allergy. First published: 26 July 2021
Prevention of infant eczema by neonatal Bacillus Calmette–Guérin vaccination: the MIS BAIR randomised controlled trial
Pittet, L.F., Messina, N.L., Gardiner, K., et al. Allergy. First published: 26 July 2021
Large scale regulatory T cells screening
Benamar, M. and Charbonnier, L.-M. Allergy. First published: 22 July 2021
The food, the bug, and the ugly: A recipe for food-induced gut pain
Rondeau, L., De Palma, G. and Caminero, A. Allergy. First published: 22 July 2021
Hypersensitivity Pneumonitis: Current Concepts in Pathogenesis, Diagnosis, and Treatment
B, H., Troy, L., Lee, C.T., Sperling, A., Strek, M. and Glaspole, I.Allergy. First published: 22 July 2021
Long-term prevention of hereditary angioedema attacks with lanadelumab: the HELP OLE Study
Banerji, A., Bernstein, J.A., Johnston, D.T., et al. Allergy. First published: 21 July 2021
Evolution and Long-Term Outcomes of Combined Immunodeficiency Due to CARMIL2 Deficiency
Kolukisa, B., Baser, D., Akcam, B., et al. Allergy. First published: 20 July 2021
Immunological effects of adjuvanted low-dose allergoid allergen-specific immunotherapy in experimental murine house dust mite allergy
Heldner, A., Alessandrini, F., Russkamp, D., et al. Allergy First published: 20 July 2021
Identification of novel biomarkers to distinguish bradykinin-mediated angioedema from mast cell-/histamine-mediated angioedema
Bindke, G., Gehring, M., Wieczorek, D., Kapp, A., Buhl, T. and Wedi, B. First published: 20 July 2021
Antibody response after one and two jabs of the BNT162b2 vaccine in nursing home residents: The CONsort-19 study
Blain, H., Tuaillon, E., Gamon, L., et al. Allergy. First published: 19 July 2021
Potential cancer risk with omalizumab? A disproportionality analysis of the WHO's VigiBase pharmacovigilance database
Mota, D., Rama, T.A., Severo, M. and Moreira, A. Allergy. First published: 16 July 2021
Reduced IL-31 receptor alpha splice variant mRNA following allergen challenge in a canine model of atopic dermatitis
Craig, N., Ahrens, K., Wilkes, R. and Marsella, R. Allergy. First published: 13 July 2021
Early intervention and prevention of allergic diseases
Brough, H., Lanser, B.J., Sindher, S.B., et al. Allergy. First published: 13 July 2021
Medical algorithm: Aspergillus fumigatus components in the diagnosis of Allergic Bronchopulmonary Aspergillosis
Lukaszewicz, R., Mahay, G., Boyer, O. and Martinet, J. Allergy First published: 12 July 2021
A bird's eye view on the role of dendritic cells in SARS-CoV-2 infection: perspectives for immune-based vaccines
Galati, D., Zanotta, S., Capitelli, L. and Bocchino, M. First published: 10 July 2021
An exhausted phenotype of TH2 cells is primed by allergen exposure, but not reinforced by allergen- specific immunotherapy
Zimmer, J., Schmidt, S., Kaul, S., et al. Allergy. First published: 9 July 2021
Molecular definition of SARS-CoV-2 RBD mutations: receptor affinity versus neutralization of receptor interaction
Vogel, M., Augusto, G.S., Chang, X., et al. Allergy. First published: 08 July 2021
Recent Patents in Allergy and Immunology: Development and preclinical evaluation of a vaccine targeting IL-4 and IL-13 for the treatment of allergic asthma
Conde, E., Bruhns, P., Serra, V. and Reber, L.L. Allergy. First published: 05 July 2021
Type 2 biomarker expression (FeNO and blood eosinophils) is higher in severe adult-onset than in severe early-onset asthma
Lommatzsch, M., Klein, M., Stoll, P. and Virchow, J.C. Allergy. First published: 03 July 2021
Immune response to SARS-CoV-2 and mechanisms of immunopathological changes in COVID-19
Azkur, A.,K., Akdis, M., Azkur, D., Sokolowska, M., van de Veen, W., Brüggen, M.,C. et al. Allergy. 2020; 75: 1564– 1581
Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China
Zhang, J.-J., Dong, X., Cao, Y.-Y., Yuan, Y.-D., Yan, Y.-Q., Akdis, C., A. and Gao, Y.-D. Allergy. 2020; 75: 1730– 1741
Unexplained recurrent fever: when is autoinflammation the explanation?
Kallinich, T., Gattorno, M., Grattan, C.,E., de Koning, H.,D., Traidl-Hoffmann, C., Feist, E., et al. Allergy. 2013; 68: 285– 296
The EAACI/GA2LEN/EDF/WAO guideline for the definition, classification, diagnosis and management of urticaria
Zuberbier, T., Aberer, W., Asero, R., Abdul Latiff, A., H., Baker, D., Ballmer-Weber, B. et al. Allergy. 2018; 73: 1393- 1414
A compendium answering 150 questions on COVID-19 and SARS-CoV-2
Riggioni, C., Comberiati, P., Giovannini, M., Agache, I., Akdis, M., Alves-Correia, M. et al. Allergy. 2020; 75: 2503– 2541
Cabbage and fermented vegetables: From death rate heterogeneity in countries to candidates for mitigation strategies of severe COVID-19
Bousquet, J., Anto, J.M., Czarlewski, W., Haahtela, T. Fonseca, S.,C., Iaccarino, G. et al. Allergy. 2021; 76: 735– 750
Eleven faces of coronavirus disease 2019
Dong, X., Cao, Y.-Y., Lu, X.-X., Zhang, Du, H., J.-J., Yan, Y.-Q. et al. Allergy. 2020; 75: 1699– 1709
Thirty-six COVID-19 cases preventively vaccinated with mumps-measles-rubella vaccine: All mild course
Larenas-Linnemann, D.,E. and Rodríguez-Monroy, F. Allergy. 2021; 76: 910-914
Allergic rhinitis and its impact on asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen)
Bousquet, J., Khaltaev, N., Cruz, A.A., Denburg, J., Fokkens, W.J., Togias, A. et al. Allergy. 2008; 63: 8-160
Asthma and COVID-19: Is asthma a risk factor for severe outcomes?
Johnston, S.,L. Allergy. 2020; 75: 1543-1545
Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China
Zhang, J.-J., Dong, X., Cao, Y.-Y., Yuan, Y.-D., Yan, Y.-Q., Akdis, C., A. and Gao, Y.-D. Allergy. 2020; 75: 1730– 1741
COVID-19 in a designated infectious diseases hospital outside Hubei Province, China
Cai, Q., Huang, D., Ou, P., Yu, H., Zhu, Z., Xia, Z. et al. Allergy. 2020; 75: 1742– 1752
Immune response to SARS-CoV-2 and mechanisms of immunopathological changes in COVID-19
Azkur, A.,K., Akdis, M., Azkur, D., Sokolowska, M., van de Veen, W., Brüggen, M.,C. et al. Allergy. 2020; 75: 1564– 1581
Distinct characteristics of COVID-19 patients with initial rRT-PCR-positive and rRT-PCR-negative results for SARS-CoV-2
Zhang, J.-j., Cao, Y.-y., Dong, X., Wang, B.-c., Liao, M.-y., Lin, J. et al. Allergy. 2020; 75: 1809-1812
Eleven faces of coronavirus disease 2019
Dong, X., Cao, Y.-Y., Lu, X.-X., Zhang, Du, H., J.-J., Yan, Y.-Q. et al. Allergy. 2020; 75: 1699– 1709
Distribution of ACE2, CD147, CD26, and other SARS-CoV-2 associated molecules in tissues and immune cells in health and in asthma, COPD, obesity, hypertension, and COVID-19 risk factors
Radzikowska, U., Ding, M., Tan, G., Zhakparov, D., Peng, Y., Wawrzyniak, P. et al. Allergy. 2020; 75: 2828– 2844
Is BCG vaccination affecting the spread and severity of COVID-19?
Ozdemir, C., Kucuksezer, U.,C. and Tamay, Z.,U. Allergy. 2020; 75: 1824-1827
Is global BCG vaccination-induced trained immunity relevant to the progression of SARS-CoV-2 pandemic?
Gursel, M. and Gursel, I. Allergy. 2020; 75: 1815-1819
Special Issue: Perspectives in Allergen Immunotherapy: 2019 and Beyond
Volume 74 | Issue S108
Basophil activation test: A diagnostic, predictive and monitoring assay for allergen immunotherapy
Alpan, O., Layhadi, J.A., Ulrik Sønder, S., Li, H. and Shamji, M.H. Allergy. 2021; 76: 1321-1324
Anaphylaxis to drugs: Overcoming mast cell unresponsiveness by fake antigens
Pichler, W.,J. Allergy. 2021; 76: 1340– 1349
The axis of the receptor for advanced glycation endproducts in asthma and allergic airway disease
Perkins, T.,N, Donnell, M.,L, Oury, T.,D. Allergy. 2021; 76: 1350– 1366
The global burden of illness of peanut allergy: A comprehensive literature review
Lieberman, J.,A, Gupta, R., Knibb, R.,C., Haselkorn, T., Tilles, S., Mack, D., P. and Poussel, G. et al. Allergy. 2021; 76: 1367– 1384
Butyrate as a bioactive human milk protective component against food allergy
Paparo, L, Nocerino, R, Ciaglia, E, et al. Allergy. 2021; 76: 1398– 1415
Predicting food allergy: The value of patient history reinforced
Lyons, SA, Knulst, AC, Burney, PGJ, et al. Allergy. 2021; 76: 1454– 1462
Identification of Pru du 6 as a potential marker allergen for almond allergy
Kabasser, S, Hafner, C, Chinthrajah, S, et al. Allergy. 2021; 76: 1463– 1472
Peanut-induced anaphylaxis in children and adolescents: Data from the European Anaphylaxis Registry
Maris, I., Dölle-Bierke, S., Renaudin, J.-M., Lange, L., Koehli, A., Spindler, T. et al. Allergy. 2021; 76: 1517-1527
Pollen induces reactivation of latent herpesvirus and differentially affects infected and uninfected murine macrophages
Speidel, J.D., Gilles, S., Steer, B., Vafadari, B., Rauer, D., Traidl-Hoffmann, C. and Adler, H. Allergy. 2021; 76: 1539-1542
PIPE-cloned human IgE and IgG4 antibodies: New tools for investigating cow's milk allergy and tolerance
Pranger, C.L., Fazekas-Singer, J., Köhler, V.K., Pali-Schöll, I., Fiocchi, A., Karagiannis, S.N. et al. Allergy. 2021; 76: 1553-1556
Assessing the protective role of allergic disease in gastrointestinal tract cancers using Mendelian randomization analysis
Yuan, S., Vithayathil, M., Kar, S., Carter, P., Mason, A.M., Xie, S.-H., Burgess, S. and Larsson, S.C. Allergy. 2021; 76: 1559-1562
Regional differences in ACE2 expression in the sinonasal mucosa of adult Chinese patients with chronic rhinosinusitis
Werner, P. et al.
Trained immunity and allergy: State of the art and future perspectives
Wang, H., Song, J., Pan, L., Deng, Y.-K., Yao, Y., Wang, Z.-C. et al. Allergy. 2021; 76: 1565-1568
Elucidating the α-Gal syndrome at the molecular allergen level
Kiewiet, M.B.G., Grundström, J., Apostolovic, D., Andersson, M., Borres, M.P., Hamsten, C. et al. Allergy. 2021; 76: 1576-1578
The roadmap for allergology in Europe: The European training requirements for the specialty of allergology
Gerth van Wijk, R., Mülleneisen, N., Demoly, P., Olaguibel, J.M., Popov, T.A., Schmid-Grendelmeier, P. and Tsilochristou, O. Allergy. 2021; 76: 1588-1591
Junior Members Corner
Dear JMs,
The EAACI 2021 Annual Congress will be taking place on 10 - 12 July in a hybrid format, with both a physical part that will be held in Krakow both a digital part to allow anybody to attend safely. You are still on time to register by clicking here to have full live access to EAACI Hybrid Congress 2021 (3 days) and full access On Demand until December 31, 2021.
This is the main event of the Academy, and one of the biggest international dedicated to Allergy and Clinical Immunology. It gathers thousands of delegates from all around the world, and offers simultaneous sessions covering all aspects of our specialty.
Don't miss this opportunity and join us!
As every year the Junior Member Assembly (JMA) has organised some meetings to share knowledge and opportunity among JMs.
Here the Agenda with the highly suggested appointments:
- Monday, 28 June 2021, 15:00-16:00 CET: Open JM Business Meeting.
Invited guest Prof. Cezmi Akdis with the talk “Future direction of epithelial barrier research in the allergy and immunology field”. You can register by clicking here.
- Saturday, 10 July 2021, 14:00-15:30 CET: JMA Scientific Symposium.
Three excellent speeches on the theme "Approaching infants at high risk of allergic disease":
- Dr R. Jiménez-Saiz, “Understanding immunological mechanisms that confer a higher risk of allergy”;
- Dr M. M. Kelleher, “Infants at high risk of food allergy: nutritional and skin barrier repair interventions”;
- Dr I. Eguiluz-Gracia, “Exposome modulation and immunotherapy in infants at higher risk of respiratory allergies”.
- Sunday, 11 July 2021, 14:00-15:30 CET: JMA Educational Session.
Composed of three very current speeches on "Lessons learned from COVID-19 pandemic":
- Dr A. DunnGalvin, “Mental health during the COVID-19 pandemic: how to cope with job stress and build resilience”;
- “Infodemic and the lesson of the COVID-19 pandemic: how to tackle health-related misinformation”;
- Dr B. Moya, “COVID-19 vaccination: Separating facts from fiction for your patients”.
Save the dates!
Looking forward to meeting you all at the 2021 EAACI Annual Hybrid Congress!
Best regards,
The Junior Member Assembly
